Geode Capital Management, LLC Enveric Biosciences, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$8.8 - $16.2 $334,681 - $616,118	38,032 Added 22.84%	204,569 $43,000
Q4 2021 Feb 11, 2022	BUY	$46.5 - $104.0 $2.38 Million - $5.33 Million	51,275 Added 44.49%	166,537 $154,000
Q3 2021 Nov 12, 2021	BUY	$80.5 - $175.0 $1.32 Million - $2.86 Million	16,368 Added 16.55%	115,262 $238,000
Q2 2021 Aug 13, 2021	BUY	$95.0 - $156.5 $3.4 Million - $5.6 Million	35,800 Added 56.74%	98,894 $235,000
Q1 2021 May 12, 2021	BUY	$131.5 - $245.0 $8.3 Million - $15.5 Million	63,094 New	63,094 $193,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.